MBL2 Gene Mannose-binding protein deficiency Genetic Test
Components: MBL2 Gene Mannose-binding protein deficiency Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MBL2 Gene Mannose-binding protein deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Mannose-binding protein deficiency.
Test Details
The MBL2 gene, also known as the mannose-binding lectin 2 gene, provides instructions for producing a protein called mannose-binding lectin (MBL). MBL is an important component of the immune system and plays a role in recognizing and binding to certain types of bacteria, viruses, and other pathogens.
MBL deficiency is a condition characterized by lower than normal levels of MBL in the blood. This deficiency can lead to an increased susceptibility to infections, particularly those caused by bacteria that have specific sugar molecules on their surface.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA. It can identify specific variations or mutations in the MBL2 gene that may be associated with MBL deficiency.
By analyzing the MBL2 gene using NGS technology, healthcare professionals can determine if an individual has a genetic variation or mutation that may cause MBL deficiency. This information can help in diagnosing the condition and guiding appropriate treatment and management strategies.
It is important to note that MBL deficiency is a complex condition, and not all individuals with genetic variations or mutations in the MBL2 gene will develop symptoms or have clinical manifestations. Other factors, such as the presence of other genetic variations or the individual’s overall immune system function, can influence the likelihood and severity of infections.
If you are considering an MBL2 gene NGS genetic test, it is recommended to consult with a healthcare professional or a genetic counselor who can provide more information about the test, its implications, and the potential benefits and limitations of genetic testing.
Test Name | MBL2 Gene Mannose-binding protein deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MBL2 Gene Mannose-binding protein deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Mannose-binding protein deficiency |
Test Details |
The MBL2 gene, also known as the mannose-binding lectin 2 gene, provides instructions for producing a protein called mannose-binding lectin (MBL). MBL is an important component of the immune system and plays a role in recognizing and binding to certain types of bacteria, viruses, and other pathogens. MBL deficiency is a condition characterized by lower than normal levels of MBL in the blood. This deficiency can lead to an increased susceptibility to infections, particularly those caused by bacteria that have specific sugar molecules on their surface. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA. It can identify specific variations or mutations in the MBL2 gene that may be associated with MBL deficiency. By analyzing the MBL2 gene using NGS technology, healthcare professionals can determine if an individual has a genetic variation or mutation that may cause MBL deficiency. This information can help in diagnosing the condition and guiding appropriate treatment and management strategies. It is important to note that MBL deficiency is a complex condition, and not all individuals with genetic variations or mutations in the MBL2 gene will develop symptoms or have clinical manifestations. Other factors, such as the presence of other genetic variations or the individual’s overall immune system function, can influence the likelihood and severity of infections. If you are considering an MBL2 gene NGS genetic test, it is recommended to consult with a healthcare professional or a genetic counselor who can provide more information about the test, its implications, and the potential benefits and limitations of genetic testing. |